GSK2118436
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for GSK2118436, covering 2013-11-21 to 2017-11-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors [Phase 1]